Editorial: similar risk of hepatocellar carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir—new clues from Europe

Pietro Lampertico, George V. Papatheodoridis

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)657-658
Number of pages2
JournalAlimentary Pharmacology and Therapeutics
Issue number5
Publication statusPublished - Mar 2021

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology
  • Pharmacology (medical)

Cite this